7-95363596-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000940.3(PON3):c.695+267C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.477 in 487,068 control chromosomes in the GnomAD database, including 58,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 15798 hom., cov: 32)
Exomes 𝑓: 0.49 ( 42928 hom. )
Consequence
PON3
NM_000940.3 intron
NM_000940.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.648
Publications
7 publications found
Genes affected
PON3 (HGNC:9206): (paraoxonase 3) This gene is a member of the paraoxonase family and lies in a cluster on chromosome 7 with the other two family members. The encoded protein is secreted into the bloodstream and associates with high-density lipoprotein (HDL). The protein also rapidly hydrolyzes lactones and can inhibit the oxidation of low-density lipoprotein (LDL), a function that is believed to slow the initiation and progression of atherosclerosis. Alternatively spliced variants which encode different protein isoforms have been described; however, only one has been fully characterized. [provided by RefSeq, Jul 2008]
PON3 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 7-95363596-G-A is Benign according to our data. Variant chr7-95363596-G-A is described in ClinVar as Benign. ClinVar VariationId is 1239780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.718 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.442 AC: 66920AN: 151544Hom.: 15791 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
66920
AN:
151544
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.494 AC: 165578AN: 335410Hom.: 42928 Cov.: 2 AF XY: 0.501 AC XY: 89715AN XY: 179100 show subpopulations
GnomAD4 exome
AF:
AC:
165578
AN:
335410
Hom.:
Cov.:
2
AF XY:
AC XY:
89715
AN XY:
179100
show subpopulations
African (AFR)
AF:
AC:
3006
AN:
9856
American (AMR)
AF:
AC:
8881
AN:
15104
Ashkenazi Jewish (ASJ)
AF:
AC:
3884
AN:
10022
East Asian (EAS)
AF:
AC:
15652
AN:
20438
South Asian (SAS)
AF:
AC:
25734
AN:
42532
European-Finnish (FIN)
AF:
AC:
9822
AN:
17690
Middle Eastern (MID)
AF:
AC:
602
AN:
1446
European-Non Finnish (NFE)
AF:
AC:
89040
AN:
199198
Other (OTH)
AF:
AC:
8957
AN:
19124
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3935
7871
11806
15742
19677
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.441 AC: 66948AN: 151658Hom.: 15798 Cov.: 32 AF XY: 0.456 AC XY: 33819AN XY: 74138 show subpopulations
GnomAD4 genome
AF:
AC:
66948
AN:
151658
Hom.:
Cov.:
32
AF XY:
AC XY:
33819
AN XY:
74138
show subpopulations
African (AFR)
AF:
AC:
12115
AN:
41154
American (AMR)
AF:
AC:
8257
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
1401
AN:
3470
East Asian (EAS)
AF:
AC:
3802
AN:
5158
South Asian (SAS)
AF:
AC:
2984
AN:
4820
European-Finnish (FIN)
AF:
AC:
6248
AN:
10564
Middle Eastern (MID)
AF:
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30542
AN:
67928
Other (OTH)
AF:
AC:
928
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1812
3623
5435
7246
9058
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2255
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.